Lobular endocervical glandular hyperplasia as a presumed precursor of cervical adenocarcinoma independent of human papillomavirus infection

Gynecologic Oncology

Volumn 106, Issue 2, 2007, Pages 289-298

  Nara, Masatoshi ^a   Hashi, Akihiko ^a   Murata, Shin Ichi ^a   Kondo, Tetsuo ^a   Yuminamochi, Tsutomu ^a   Nakazawa, Kumiko ^a   Katoh, Ryohei ^a   Hoshi, Kazuhiko ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Cervical adenocarcinoma; HIK1083; Human papillomavirus; Lobular endocervical glandular hyperplasia; Treatment

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CLINICAL ARTICLE; DNA EXTRACTION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LOBULAR ENDOCERVICAL GLANDULAR HYPERPLASIA; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TREATMENT PLANNING; UTERINE CERVIX CANCER; VIRUS INFECTION; WART VIRUS;

ADENOCARCINOMA; ADULT; AGED; ALPHAPAPILLOMAVIRUS; CERVIX UTERI; DNA, VIRAL; FEMALE; HUMANS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; PAPILLOMAVIRUS INFECTIONS; PRECANCEROUS CONDITIONS; UTERINE CERVICAL NEOPLASMS;

EID: 34447619720     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2007.03.044     Document Type: Article

References (28)

1. Nucci M.R., Clement P.B., and Young R.T. Lobular endocervical glandular hyperplasia, not otherwise specified. Am J Surg Pathol 23 (1999) 886-891
2. Ishii K., Hosaka N., Toki T., Momose M., Hidaka E., Tsuchiya S., et al. A new view of the so-called adenoma malignum of the uterine cervix. Virchows Arch 432 (1998) 315-322
3. Utsugi K., Hirai Y., Takeshima N., Akiyama F., Sakurai S., and Hasumi K. Utility of the monoclonal antibody HIK 1083 in the diagnosis of adenoma malignum of the uterine cervix. Gynecol Oncol 75 (1999) 345-348
4. Ishii K., Kumagai T., Tozuka M., Ota H., Katsuyama T., and Kurihara M. A new diagnostic method for adenoma malignum and related lesions: latex agglutination test with a new monoclonal antibody, HIK 1083. Clin Chim Acta 312 (2001) 231-233
5. Mikami Y., Hata S., Fujiwara K., Imajo Y., Kohno I., and Manabe T. Floid endocervical glandular hyperplasia with intestinal and pyloric gland metaplasia: worrisome benign mimic of "adenoma malignum". Gynecol Oncol 74 (1999) 504-511
6. Mikami Y., Hata S., Melamed J., Fujiwara K., and Manabe T. Lobular endocervical glandular hyperplasia is a metaplastic process with a pyloric gland phenotype. Histopathology 39 (2001) 364-372
7. Zhao S., Hayasaka T., Osakabe M., Kato N., Nakahara K., Kurachi H., et al. Mucin expression in nonneoplastic and neoplastic glandular epithelia of the uterine cervix. Int J Gynecol Pathol 22 (2003) 393-397
8. Mikami Y., Kiyokawa T., Hata S., Fujiwara K., Moriya T., Sasano H., et al. Gastrointestinal immunophenotype in adenocarcinomas of the uterine cervix and related glandular lesions: a possible link between lobular endocervical glandular hyperplasia/pyloric gland metaplasia and 'adenoma malignum'. Mod Path 17 (2004) 962-972
9. Kondo T., Hashi A., Murata S., Nakazawa T., Yuminamochi T., Nara M., et al. Endocervical adenocarcinomas associated with lobular endocervical glandular hyperplasia: a report of four cases with histochemical and immunohistochemical analyses. Mod Path 18 (2005) 1199-1210
10. Tuda H., Okada S., and Kasamatsu T. Is florid pyloric metaplasia different from adenoma malignum?. Gynecol Oncol 77 (2000) 341-343
11. Fattaneh A., Tavassoli, and Devilee P. World Health Organization Classification of tumors. Pathology and genetics of tumors of the breast and female genital organs (2003), IARC press, Lyon
12. In: Sobin L.H., and Wittekind C.H. (Eds). TNM classification of malignant tumors. 6th edn. (2002), Wiley-Liss, New York
13. Xu J.-Y., Hashi A., Kondo T., Yuminamochi T., Nara M., Hashi K., et al. Absence of human papillomavirus infection in minimal deviation adenocarcinoma and lobular endocervical glandular hyperplasia. Int J Gynecol Pathol 24 (2005) 296-302
14. Unger E.R. In situ diagnosis of human papillomaviruses. Clin Lab Med 20 (2000) 289-301
15. Birner P., Bachtiary B., Dreier B., Schindl M., Joura E.A., Breitenecker G., et al. Signal-amplified colorimetric in situ hybridization for assessment of human papillomavirus infection in cervical lesions. Mod Path 14 (2001) 702-709
16. Andersen E.S., and Arffmann E. Adenocarcinoma in situ of the uterine cervix: a clinico-pathologic study of 36 cases. Gynecol Oncol 35 (1989) 1-7
17. Bertrand M., Lickrish G.M., and Colgan T.J. The anatomic distribution cervical adenocarcinoma in situ: implications for treatment. Am J Obstet Gynecol 157 (1987) 21-25
18. Teshima S., Shimosato Y., Kishi K., Kasamatsu T., Ohmi K., and Uei Y. Early stage adenocarcinoma of the cervix. Histopathologic analysis with consideration of histogenesis. Cancer 56 (1985) 167-172
19. Parkin D.M., Pisani P., and Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 80 (1990) 827-841
20. Franco E.L., Rohan T.E., and Villa L.L. Epidemiologic evidence and human papillomavirus infection as a necessary cause of cervical cancer. J Natl Cancer Inst 6 (1999) 506-511
21. Clifford G.M., Smith J.S., Plummer M., Munoz N., and Franceshi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 88 (2003) 63-73
22. Walboomers J.M., Jacobs M.V., Michele Manos M., Bosch F.X., Kummer J.A., Shah KV., et al. Human papillomavirus is a necessary cause of invasive cervical cancer world wide. J Pathol 189 (1999) 12-19
23. Sasagawa T., Basha W., Yamazaki H., and Inoue M. High-risk and multiple human papillomavirus infections associated with cervical abnormalities in Japanese women. Cancer Epidemiol Biomark Prev 10 (2001) 45-52
24. Andersson S., Rylander E., Larsson B., Strand A., Silfversvard C., and Wilander E. The role of human papillomavirus in cervical adenocarcinoma carcinogenesis. Eur J Cancer 37 (2001) 246-250
25. Madeleine M.M., Daling J.R., Schwartz S.M., Shera K., McKnight B., Carter J.J., et al. Human papillomavirus and long-term oral contraceptive use increase the risk of adenocarcinoma in situ of the cervix. Cancer Epidemiol Biomark Prev 10 (2001) 171-177
26. Smith J.S., Green J., Berrington de Gonzalez A., Appleby P., Peto J., Plummer M., et al. Cervical cancer and use of hormonal contraceptives: a systematic review. Lancet 361 (2003) 1159-1167
27. Lacey Jr. J.V., Brinton L.A., Barnes W.A., Gravitt P.E., Greenberg M.D., Hadjimichael O.C., et al. Use of hormone replacement therapy and adenocarcinomas and squamous cell carcinomas of the uterine cervix. Gynecol Oncol 77 (2000) 149-154
28. Tsuda H., Mikami Y., Kaku T., Hasegawa T., Akiyama F., Ohishi Y., et al. Reproducible and clinically meaningful differential diagnosis is possible between lobular endocervical glandular hyperplasia and 'adenoma malignum' based on common histopathological criteria. Pathol Int 55 (2005) 412-418